- Research Plus
- Portfolios & Watchlists
- Charting
- Screening Tools
- Visual Tools
- Education Guides
- UK Shares
- Funds
- International Shares
- Gilts
- Currencies
- Commodities
- Company Diary
- Free Brochures
- ETF Centre
- Real Time
Open End and Miscellaneous Investment Vehicles (8990)
- 52 Week High: NULL
- 52 Week Low: 0.00
Latest ShareCast News
Crism Therapeutics gets clearance for UK phase 2 trial
By Josh White
Date: Monday 01 Sep 2025
(Sharecast News) - Crism Therapeutics said on Monday that it has received both regulatory clearance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) and ethical approval from a UK Research Ethics Committee to begin its registration-grade phase two trial of irinotecan-ChemoSeed in glioblastoma patients.
Crism reports progress with ChemoSeed drug delivery platform
By Josh White
Date: Tuesday 26 Aug 2025
(Sharecast News) - Crism Therapeutics used its annual general meeting on Tuesday to highlight progress on its ChemoSeed drug delivery platform as it advances towards key clinical milestones.
Celadon proposes delisting, re-registration as private company
By Josh White
Date: Wednesday 02 Jul 2025
(Sharecast News) - Celadon Pharmaceuticals announced on Wednesday that it intends to delist its shares from AIM and re-register as a private limited company, subject to shareholder approval.
Price Data
| Price | 0.00 |
| Closing Price Change | 0.00 |
| % Change | 0.00 % |
| --25 Close | 0.00 |
Top Risers
You are here: research
10 Lower Thames St,
London EC3R 6EN